301 related articles for article (PubMed ID: 14612105)
1. Omission of azathioprine and mycophenolate mofetil in immunosuppressive regimen in kidney transplantation.
Taheri M; Pourmand G; Mehrsai AR; Mansoori D
Transplant Proc; 2003 Nov; 35(7):2752-3. PubMed ID: 14612105
[No Abstract] [Full Text] [Related]
2. Safety and efficacy of mycophenolate mofetil for prophylaxis in Asian renal transplant recipients.
Suhail SM; Vathsala A; Lou HX; Woo KT
Transplant Proc; 2000 Nov; 32(7):1757-8. PubMed ID: 11119922
[No Abstract] [Full Text] [Related]
3. Triple therapy with mycophenolate mofetil versus azathioprine.
Muñiz ML; Amenabar J; Gómez-Ullate P; Urbizu J; Lampreabe I
Transplant Proc; 1999; 31(1-2):1144-6. PubMed ID: 10083512
[No Abstract] [Full Text] [Related]
4. Tolerability of mycophenolate mofetil in organ transplant recipients.
Schweizer RT; Meisterling LD
Transplant Proc; 2001 May; 33(3):2309. PubMed ID: 11377540
[No Abstract] [Full Text] [Related]
5. Efficacy and safety of mycophenolate mofetil in different dosages in Asian renal allograft recipients.
Tsang WK; Tong KL; Yeung S; Lee W; Chan HW
Transplant Proc; 2000 Nov; 32(7):1755-6. PubMed ID: 11119921
[No Abstract] [Full Text] [Related]
6. Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine.
Fabrega AJ; Corwin CL; Hunsicker L
Transplant Proc; 1998 Jun; 30(4):1562-3. PubMed ID: 9636634
[No Abstract] [Full Text] [Related]
7. Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
Esmeraldo RM; Donadi MO; Oliveira ML; Ponte CN; Pinheiro PM
Transplant Proc; 1999 Nov; 31(7):3007-8. PubMed ID: 10578367
[No Abstract] [Full Text] [Related]
8. Comparison between mycophenolate mofetil and azathioprine based immunosuppression in pediatric renal transplantation from living related donors.
Antoniadis A; Papachristou F; Gakis D; Takoudas D; Sotiriou I
Transplant Proc; 1998 Dec; 30(8):4085-6. PubMed ID: 9865305
[No Abstract] [Full Text] [Related]
9. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
Johnson C; Ahsan N; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; van Veldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
Transplantation; 2000 Mar; 69(5):834-41. PubMed ID: 10755536
[TBL] [Abstract][Full Text] [Related]
10. Transplantation without maintenance corticosteroids in 1-haplotype and 2-haplotype HLA matched living-related renal transplant recipients treated with mycophenolate mofetil and cyclosporine.
Kupin W; Venkat KK; Goggins M; Douzdjian V; Escobar F; Mozes M; Abouljoud M
Transplant Proc; 1999; 31(1-2):744-5. PubMed ID: 10083317
[No Abstract] [Full Text] [Related]
11. Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipients.
Smak Gregoor PJ; Hesse CJ; van Gelder T; van der Mast BJ; IJzermans JN; van Besouw NM; Weimar W
Transplant Proc; 1998 Jun; 30(4):1192-3. PubMed ID: 9636482
[No Abstract] [Full Text] [Related]
12. Chronic allograft nephropathy: a prospective randomised trial of cyclosporin reduction with or without mycophenolate mofetil.
Jain S; Metcalfe M; White SA; Furness PN; Nicholson ML
Transplant Proc; 2001 May; 33(3):2165-6. PubMed ID: 11377488
[No Abstract] [Full Text] [Related]
13. Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy.
Zucker K; Rosen A; Tsaroucha A; de Faria L; Roth D; Ciancio G; Esquenazi V; Burke G; Tzakis A; Miller J
Transplant Proc; 1997; 29(1-2):334-6. PubMed ID: 9123027
[No Abstract] [Full Text] [Related]
14. One and a half years of experience with mycophenolate mofetil (Cellcept) in cardiac transplantation: a prospective, randomized study.
Seebacher G; Weigel G; Griesmacher A; Mallinger R; Zuckermann A; Grimm M; Laufer G
Transplant Proc; 1999 Dec; 31(8):3291-3. PubMed ID: 10616480
[No Abstract] [Full Text] [Related]
15. Mycophenolate mofetil and reduction in cyclosporine dosage for chronic renal allograft dysfunction.
Islam MS; Francos GC; Dunn SR; Burke JF
Transplant Proc; 1998 Aug; 30(5):2230-1. PubMed ID: 9723452
[No Abstract] [Full Text] [Related]
16. Effects of mycophenolate mofetil on hematocrit after renal transplantation.
Chenhsu RY; Wu YM; Min DI; Zimmerman MB
Ann Pharmacother; 2002 Sep; 36(9):1479-80. PubMed ID: 12196073
[No Abstract] [Full Text] [Related]
17. Effect of mycophenolate mofetil on the prevention of acute renal allograft rejection.
Miladipour AH; Ghods AJ; Nejadgashti H
Transplant Proc; 2002 Sep; 34(6):2089-90. PubMed ID: 12270325
[No Abstract] [Full Text] [Related]
18. Management of massive proteinuria following renal transplantation with mycophenolate mofetil and blood pressure normalization.
Nakache R; Weinbroum A; Merhav H; Katz P; Kaplan E
Transplant Proc; 2001 May; 33(3):2294-5. PubMed ID: 11377533
[No Abstract] [Full Text] [Related]
19. Conversion to mycophenolate mofetil for chronic progressive deterioration of renal allograft function: first clinical experiences in 44 patients.
Fritsche L; Sperschneider H; Budde K; Giessing M; Morgera S; Schröder K; Stein G; Neumayer HH
Transplant Proc; 1998 Jun; 30(4):1190-1. PubMed ID: 9636481
[No Abstract] [Full Text] [Related]
20. Mycophenolate mofetil in ongoing chronic kidney allograft dysfunction.
Senn B; Rochat P; Schwarzkopf AK; Weinreich T; Binswanger U
Transplant Proc; 1998 Dec; 30(8):4075-6. PubMed ID: 9865301
[No Abstract] [Full Text] [Related]
[Next] [New Search]